Coherus BioSciences, Inc. (NASDAQ:CHRS) Q2 2025 Earnings Call Transcript August 9, 2025
Operator: Thank you for standing by. My name is Jordan, and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Coherus Oncology earnings conference call. [Operator Instructions] I’d now like to turn the conference over to Jodi Sievers, Head of Investor Relations for Coherus Oncology. You may begin.
Jodi Sievers: Thank you, Jordan. Good afternoon, and welcome to...
